Nutra

The constraint is the claim, not the creative

Nutra converts on before-and-after, on speed, and on specificity — which is exactly the material platforms and regulators exist to restrict. Personal health claims, implied medical outcomes, weight-loss promises with numbers attached and imagery suggesting a physical transformation are all routinely rejected, and in several markets they are also a regulatory matter independent of any ad platform.

So the interesting work is not producing a stronger claim. It is finding the strongest claim that is both true and permissible, and building the page so that the reader arrives at the conclusion without being handed a prohibited sentence.

Pre-landers

The pre-lander is inspected as carefully as the ad, and it is where most of this vertical's account losses originate. Fake news formats, invented endorsements, borrowed regulator or broadcaster branding and fabricated comment sections are not grey — they are the specific things review is trained on, and they take the whole asset with them. A legitimate pre-lander does the same job: qualify the reader, set the frame, make the offer make sense. It just has to earn it.

What we build

• Angles ranked by what the product can actually support, with the unsupportable ones named as unsupportable rather than quietly softened.
• Creative sets produced at the volume this vertical burns through, with rejection reasons logged so the same idea does not return under a new filename.
• Landing and pre-landing pages written by people who know which sentence is the problem — see copywriting.

Geography changes the rules

What is permissible for a supplement in one market is a medicine claim in another, and the same creative may be fine in three countries and actionable in the fourth. The market list is decided before production, because it changes what can be produced.